Evaluation of perception of insulin therapy among Chinese patients with type 2 diabetes mellitus

Diabetes and Metabolism

Volumn 37, Issue 5, 2011, Pages 389-394

  Chen, C C ^a,b   Chang, M P ^c   Hsieh, M H ^a   Huang, C Y ^a   Liao, L N ^b   Li, T C ^b,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c National Taichung Nursing College   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Chinese; Insulin Treatment Appraisal Scale; Perception; Psychological insulin resistance; Type 2 diabetes mellitus

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ACADEMIC ACHIEVEMENT; ADULT; AGED; ARTICLE; CHINESE; CORRELATION ANALYSIS; FEMALE; HUMAN; INJECTION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; RATING SCALE; SEX DIFFERENCE; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PERCEPTION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 81055129365     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.12.008     Document Type: Article

References (21)

1. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431.
2. The diabetes control complications trial research group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
3. Prospective diabetes study (UKPDS) UK group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853.
4. Prospective diabetes study (UKPDS) UK group UK prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995, 44:1249-1258.
5. Kahn S.E., Haffner S.M., Heise M.A., Herman W.H., Holman R.R., Johnes N.P., et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006, 355:2427-2443.
6. Tuner R.C., Cull C.A., Frighi V., Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 1999, 281:2005-2012. For the UK prospective diabetes study group.
7. Prospective diabetes study (UKPDS) UK group United Kingdom prospective diabetes study 24: a 6-year randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 1998, 128:165-175.
8. Peyrot M., Rubin R.R., Lauritzen T., Skovlund S.E., Snoek F.J., Matthews D.R., et al. Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study. Diabetes Care 2005, 28:2673-2679.
9. Polonsky W.H., Fisher L., Guzman S., Villa-Caballero L., Edelman S.V. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005, 28:2543-2545.
10. Snoek F.J., Skovlund S.E., Pouwer F. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcomes 2007, 5:69-74.
11. Koo L.C. The use of food to treat and prevent disease in Chinese culture. Soc Sci Med 1984, 18:757-766.
12. Zhang J., Verhoef M.J. Illness management strategies among Chinese immigrants living with arthritis. Soc Sci Med 2002, 55:1795-1802.
13. Lai W.A., Lew-Ting C.Y., Chie W.C. How diabetic patients think about and manage their illness in Taiwan. Diabet Med 2005, 22:286-292.
14. Chang M.P., Huang C.Y., Li T.C., Liao L.N., Chen C.C. Validation of the Chinese-version of the insulin treatment appraisal scale. J Diabetes Invest 2010, 1(suppl 1):88.
15. Chiou S.T., Lin H.D., Yu N.C., Hseuh H.K., Lin L.H., Lin L.T., et al. An initial assessment of the feasibility and effectiveness of implementing diabetes shared care system in Taiwan-some experiences from I-Lan County. Diabetes Res Clin Pract 2001, 54(suppl 1):S67-S73.
16. Fuh M.T., Lin C.C., Chiu C.S. Diabetes care in Taiwan: a case management initiative. Diabetes Voice 2006, 51:20-21.
17. Nilchaikovit T., Hill J.M., Holland J. The effects of culture on illness behavior and medical care: Asian and American differences. Gen Hosp Psychiatry 1993, 15:41-50.
18. Bott U., Jorgens V., Grusser M., Bender R., Muhlhauser I., Berqer M. Predictors of glycemic control in type 1 diabetic patients after participation in an intensified treatment and teaching program. Diabet Med 1994, 11:362-371.
19. Chen C.C., Li C.I., Chen R.H., Wang T.Y., Chang C.T., Yei K.M. Factors related to poor glycemic control in type 2 diabetic outpatients in a medical center. Mid Taiwan J Med 2005, 10:90-98.
20. Polonsky W.H., Jackson R.A. What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes 2004, 22:147-150.
21. Makine C., Karsidag C., Kadioglu P., Ilkova H., Karsidag K., Skovlund S.E., et al. Symptoms of depression and diabetes specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naïve patients with type 2 diabetes mellitus. A study from the European depression in diabetes [EDID] research consortium. Diabet Med 2008, 26:28-33.